IBDEI2A8 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38716,2)
 ;;=^5009116
 ;;^UTILITY(U,$J,358.3,38717,0)
 ;;=L23.81^^151^1897^3
 ;;^UTILITY(U,$J,358.3,38717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38717,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Animal Dander
 ;;^UTILITY(U,$J,358.3,38717,1,4,0)
 ;;=4^L23.81
 ;;^UTILITY(U,$J,358.3,38717,2)
 ;;=^5009123
 ;;^UTILITY(U,$J,358.3,38718,0)
 ;;=L23.0^^151^1897^5
 ;;^UTILITY(U,$J,358.3,38718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38718,1,3,0)
 ;;=3^Dermatitis,Allergic Contact d/t Metals
 ;;^UTILITY(U,$J,358.3,38718,1,4,0)
 ;;=4^L23.0
 ;;^UTILITY(U,$J,358.3,38718,2)
 ;;=^5009115
 ;;^UTILITY(U,$J,358.3,38719,0)
 ;;=B00.1^^151^1897^10
 ;;^UTILITY(U,$J,358.3,38719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38719,1,3,0)
 ;;=3^Dermatitis,Herpes Simplex
 ;;^UTILITY(U,$J,358.3,38719,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,38719,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,38720,0)
 ;;=L24.0^^151^1897^13
 ;;^UTILITY(U,$J,358.3,38720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38720,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Detergents
 ;;^UTILITY(U,$J,358.3,38720,1,4,0)
 ;;=4^L24.0
 ;;^UTILITY(U,$J,358.3,38720,2)
 ;;=^5009126
 ;;^UTILITY(U,$J,358.3,38721,0)
 ;;=L24.81^^151^1897^14
 ;;^UTILITY(U,$J,358.3,38721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38721,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Metals
 ;;^UTILITY(U,$J,358.3,38721,1,4,0)
 ;;=4^L24.81
 ;;^UTILITY(U,$J,358.3,38721,2)
 ;;=^5009134
 ;;^UTILITY(U,$J,358.3,38722,0)
 ;;=L24.2^^151^1897^15
 ;;^UTILITY(U,$J,358.3,38722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38722,1,3,0)
 ;;=3^Dermatitis,Irritant Contact d/t Solvents
 ;;^UTILITY(U,$J,358.3,38722,1,4,0)
 ;;=4^L24.2
 ;;^UTILITY(U,$J,358.3,38722,2)
 ;;=^5009128
 ;;^UTILITY(U,$J,358.3,38723,0)
 ;;=E08.620^^151^1897^22
 ;;^UTILITY(U,$J,358.3,38723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38723,1,3,0)
 ;;=3^Diabetes d/t Underlying Condition w/ DM Dermatitis
 ;;^UTILITY(U,$J,358.3,38723,1,4,0)
 ;;=4^E08.620
 ;;^UTILITY(U,$J,358.3,38723,2)
 ;;=^5002533
 ;;^UTILITY(U,$J,358.3,38724,0)
 ;;=E08.621^^151^1897^24
 ;;^UTILITY(U,$J,358.3,38724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38724,1,3,0)
 ;;=3^Diabetes d/t Underlying Conditions w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,38724,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,38724,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,38725,0)
 ;;=T81.33XA^^151^1897^27
 ;;^UTILITY(U,$J,358.3,38725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38725,1,3,0)
 ;;=3^Disruption Traumatic Inj/Wound Repair,Init Encntr
 ;;^UTILITY(U,$J,358.3,38725,1,4,0)
 ;;=4^T81.33XA
 ;;^UTILITY(U,$J,358.3,38725,2)
 ;;=^5054476
 ;;^UTILITY(U,$J,358.3,38726,0)
 ;;=L60.3^^151^1897^30
 ;;^UTILITY(U,$J,358.3,38726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38726,1,3,0)
 ;;=3^Dystrophic Nails
 ;;^UTILITY(U,$J,358.3,38726,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,38726,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,38727,0)
 ;;=M71.30^^151^1897^25
 ;;^UTILITY(U,$J,358.3,38727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38727,1,3,0)
 ;;=3^Digital Mucous Cyst
 ;;^UTILITY(U,$J,358.3,38727,1,4,0)
 ;;=4^M71.30
 ;;^UTILITY(U,$J,358.3,38727,2)
 ;;=^5013149
 ;;^UTILITY(U,$J,358.3,38728,0)
 ;;=L30.4^^151^1898^9
 ;;^UTILITY(U,$J,358.3,38728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38728,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,38728,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,38728,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,38729,0)
 ;;=R60.0^^151^1898^6
 ;;^UTILITY(U,$J,358.3,38729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38729,1,3,0)
 ;;=3^Edema,Localized
